Nasdaq

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its complete financial results...

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC platform for rare...

In late January 2026, ServiceNow reported quarterly financial results that surpassed even the most optimistic projections from market analysts. The...

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The biopharmaceutical firm is...

Lam Research is implementing a strategic realignment to secure its future growth trajectory. The semiconductor equipment manufacturer is responding to...

A fierce corporate battle is unfolding in the streaming sector, casting uncertainty over a landmark acquisition. Netflix's proposed $82.7 billion...

As Cloudflare prepares to announce its latest quarterly financial results, a notable shift in sentiment is emerging among market observers....

Beyond Meat faces mounting pressure as a class-action lawsuit filed on behalf of shareholders coincides with a period of strategic...

The restructuring of iRobot under Chapter 11 bankruptcy protection has concluded, resulting in the company's delisting from public stock exchanges....

The chapter for CureVac as an independent publicly traded company has officially closed. The biotech firm's shares have been removed...